Return to content in this issue

Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 Vaccine

de las Vecillas L¹*, López J¹*, Morchón E¹, Rodriguez F¹, Drake M², Martino M<sup>3

1</sup>Department of Allergy, Marqués de Valdecilla University Hospital - Instituto de Investigación Marques de Valdecilla (IDIVAL), Santander, Spain
²Department of Dermatology, Marqués de Valdecilla University Hospital - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain
³Department of Pathology, Marqués de Valdecilla University Hospital - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain
*Both can be considered first authors. 

J Investig Allergol Clin Immunol 2022; Vol 32(1) : 77-78
doi: 10.18176/jiaci.0757

• Abstract
• Supplemental Materials

Key words: COVID-19, Vaccine, Hypersensitivity erythema multiforme, Eosinophilia

	Title	Type	Size
	doi10.18176_jiaci.0757_supplemental-materials_1.pdf	pdf	173.87 Kb